Long-term tracking of murine hematopoietic cells transduced with a bicistronic retrovirus containing CD24 and EGFP genes

Gene Therapy

Volumn 7, Issue 14, 2000, Pages 1193-1199

  Kume, A ^a,b   Xu, R ^a,b   Ueda, Y ^a,b,c   Urabe, M ^a,b   Ozawa, K ^a,b,d  

^a Center for Molecular Medicine   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c DNAVEC Research Inc   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; CD24; Flow cytometry; Gene therapy; Green fluorescent protein; Hematopoietic stem cells

Indexed keywords

CD24 ANTIGEN; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSPLANTATION; CISTRON; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LYMPHOID CELL; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE; TRANSGENE;

ANIMALIA; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0033914298     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301225     Document Type: Article

References (43)

1. Treatment of genetic defects in hematopoietic cell function by gene transfer
2. Retrovirus-mediated gene transfer into human hematopoietic stem cells
3. Gene marking and gene therapy directed at primary hematopoietic cells
4. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
5. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction
6. + cells in ADA-deficient SCID neonates
7. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
8. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
9. Hematopoietic stem cell gene therapy: A current overview
10. Cell-surface markers for assessing gene transfer into human hematopoietic cells
11. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
12. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina
13. Retroviral mediated gene transfer into bone marrow progenitor cells: Use of beta-galactosidase as a selectable marker
14. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer
15. Green fluorescent protein as a marker for gene expression
16. Understanding, improving and using green fluorescent proteins
17. Understanding structure-function relationships in the Aequorea victoria green fluorescent protein
18. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein
19. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo
20. Enhanced green fluorescent protein as selectable marker of retroviral- mediated gene transfer in immature hematopoietic bone marrow cells
21. Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer
22. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors
23. Versatile retroviral vectors for potential use in gene therapy
24. Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation
25. A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome
26. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12
27. A simple and reliable method for screening retroviral producer clones without selectable markers
28. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
29. High-level reconstitution of respiratory burst activity in a human X- linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91(phox)
30. Developmental potential and dynamic behavior of hematopoietic stem cells
31. T cell activation modulates retrovirus-mediated gene expression
32. In vivo selection of retrovirally transduced hematopoietic stem cells
33. + cells
34. Immune response to green fluorescent protein: Implications for gene therapy
35. + cells
36. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo
37. + progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors
38. Production of high-titer helper-free retroviruses by transient transfection
39. Efficient screening of retroviral cDNA expression libraries
40. High-level direct expression of semi-synthetic human interleukin-6 in Escherichia coli and production of N-terminus Met-free product
41. Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells
42. Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy
43. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells